Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03460678
Recruitment Status : Terminated (Difficulty recruiting)
First Posted : March 9, 2018
Last Update Posted : March 5, 2020
Sponsor:
Information provided by (Responsible Party):
Hikma Pharmaceuticals LLC

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : November 14, 2018
Actual Study Completion Date : November 14, 2018